Haematology
Morphology quiz
Haematology
Morphology quiz
9am – 10am BST, 23 September 2025 ‐ 1 hour
Haematology
Abstract
A varied selection of blood cell Morphology cases, from the everyday to the complex.
Multiple choice quiz, anonymous and accessible to all levels with immediate laboratory and clinical feedback including discussion of morphology features and educational information around the cases.
Speakers

Dr Michelle Brereton
Chief Biomedical Scientist, Manchester University NHS Foundation Trust
What is sickle cell disease?
Haematology
What is sickle cell disease?
10.30am – 11am BST, 23 September 2025 ‐ 30 mins
Haematology
Learning outcomes
The delegate should be able to:
- Apply correct terminology when describing sickling disorders
- Identify the main molecular differences between the common sickling disorders
- Outline the differences in the blood count between the common sickling disorders
- Recognise the morphological differences between the common sickling disorders
Speakers

Professor Barbara Bain
Professor of Diagnostic Haematology, St Mary's Imperial College Healthcare NHS Trust
Immunophenotyping cases
Haematology
Immunophenotyping cases
11am – 11.30am BST, 23 September 2025 ‐ 30 mins
Haematology
Learning outcomes
Speakers
'Clash of the Titans’ – WHO vs ICC case studies and panel discussion
Haematology
'Clash of the Titans’ – WHO vs ICC case studies and panel discussion
11.30am – 12pm BST, 23 September 2025 ‐ 30 mins
Haematology
Learning outcomes
The delegate will be able to:
- Recognise the two main classification systems used for the diagnosis of Haematological Malignancy
- Understand why a second classification was introduced
- Recognise the differences between the two systems using case studies
- Learn from panel discussion from the morning's speakers discussing WHO
Speakers

Professor Barbara Bain
Professor of Diagnostic Haematology, St Mary's Imperial College Healthcare NHS Trust

Dr Michelle Brereton
Chief Biomedical Scientist, Manchester University NHS Foundation Trust

Nicola Lawrence
Principal Biomedical Scientist Advanced Practitioner in Morphology, University Hospitals of North Midlands NHS Trust
Reversal of anticoagulation: How the lab can make a difference
Haematology
Reversal of anticoagulation: How the lab can make a difference
9am – 9.30am BST, 24 September 2025 ‐ 30 mins
Haematology
Learning outcomes
Delegates will understand:
- The mechanism of action of available reversal agents
- The limitations of the evidence of benefit for reversal agents
- How laboratory testing could make a difference in the care of these patients
Speakers
Dr Richard Buka
Haematology Registrar, Birmingham Women’s and Children’s NHS Foundation Trust
Exploring novel biomarkers in multiple myeloma
Haematology
Exploring novel biomarkers in multiple myeloma
9.30am – 10am BST, 24 September 2025 ‐ 30 mins
Haematology
Learning outcomes
Through an overview of Multiple Myeloma delegates will be able to:
- Understand the role of novel biomarkers in tracking disease progression in multiple myeloma.
- Identify key biomarkers and their relevance in multiple myeloma.
- Evaluate the clinical implications of novel biomarkers for disease progression.
Speakers
Can we use biomarkers to predict cancer-associated thrombosis?
Haematology
Can we use biomarkers to predict cancer-associated thrombosis?
10.30am – 11am BST, 24 September 2025 ‐ 30 mins
Haematology
Abstract
- Overview of Cancer-Associated Thrombosis - its prevalence and why it is important to diagnose.
- Predictive Models which can be used to predict cancer-associated thrombosis including their pitfalls.
- How biomarkers could be used to aid this, giving a synopsis of Alison's DClinSci thesis.
Speakers
Alison Brown
Lead Healthcare Scientist - Haematology and Haemostasis, The Newcastle upon Tyne Hospitals NHS Foundation Trust
FVII/FVIIa in preeclampsia
Haematology
FVII/FVIIa in preeclampsia
11am – 11.30am BST, 24 September 2025 ‐ 30 mins
Haematology
Learning outcomes
Speakers
Gene therapy and novel therapies in haemophilia in the era of precision medicine
Haematology
Gene therapy and novel therapies in haemophilia in the era of precision medicine
11.30am – 12pm BST, 24 September 2025 ‐ 30 mins
Haematology
Speakers
Dr Rashid Kazmi
Consultant Haematologist, University Hospital Southampton NHS Foundation Trust
Next-generation flow cytometry for minimum residual disease monitoring
Haematology
Next-generation flow cytometry for minimum residual disease monitoring
2pm – 2.30pm BST, 24 September 2025 ‐ 30 mins
Haematology
Abstract
Learning outcomes
Speakers
Heparin-induced thrombocytopenia (HIT) versus thrombotic thrombocytopenic purpura (TTP): A clinical case study
Haematology
Heparin-induced thrombocytopenia (HIT) versus thrombotic thrombocytopenic purpura (TTP): A clinical case study
2.30pm – 3pm BST, 24 September 2025 ‐ 30 mins
Haematology
Abstract
- Understand the pathophysiology of HIT
- Understand the pathophysiology of TTP
- Highlight the importance of continued monitoring of laboratory results and knowledge of pathological conditions in your discipline
- Gain an overview of the diagnostic testing involved in both HIT and TTP
Speakers

When multiple inherited red cell disorders lead to severe anaemia – a case study
Haematology
When multiple inherited red cell disorders lead to severe anaemia – a case study
3pm – 3.30pm BST, 24 September 2025 ‐ 30 mins
Haematology
Learning Outcomes
Delegates will gain knowledge on:
- How inherited red cell disorder can present
- How the symptoms may be exacerbated by co-inheritance of multiple disorders.
Speakers

Advanced Roles
Haematology
Advanced Roles
4pm – 4.30pm BST, 24 September 2025 ‐ 30 mins
Haematology
Abstract
Learning outcomes
Exams in Haematology: Advancing your career
Haematology
Exams in Haematology: Advancing your career
4.30pm – 5pm BST, 24 September 2025 ‐ 30 mins
Haematology
Abstract
Delegates will hear about the IBMS exams in Haematology, including the new Diplomas of Expert Practice.
The talk will include information about the content of these exams, advice on how to study and prepare for them, and how taking the IBMS exams may help further with career development.
Speakers
Unstable haemoglobin
Haematology
Unstable haemoglobin
9am – 9.30am BST, 25 September 2025 ‐ 30 mins
Haematology
Abstract
This presentation will provide information on:
- An introduction to unstable Hb
- Causes for unstable Hb
- Clinical presentation
- Laboratory result
- Laboratory investigation
- Management of unstable Hb
Speakers

Dr Sukhjinder Marwah
Senior Biomedical Scientist in Haemoglobinopathy, Black Country Pathology Services
Total B12 or not total B12? That is the question (NICE)
Haematology
Total B12 or not total B12? That is the question (NICE)
9.30am – 10am BST, 25 September 2025 ‐ 30 mins
Haematology
Learning outcomes
Delegates will gain knowledge on:
- Vitamin B12 deficiency, clinical signs and symptoms
- Pros and cons of Total B12 testing versus Active B12
- Other available assays to identify B12 deficiency
- NG239 NICE guidance on B12 deficiency diagnosis
Speakers

Jayne Parkes
Principal Biomedical Scientist, Black Country Pathology Services, The Royal Wolverhampton NHS Trust
Reticulocyte haemoglobin EQA programme: Two years and still counting
Haematology
Reticulocyte haemoglobin EQA programme: Two years and still counting
10.30am – 11am BST, 25 September 2025 ‐ 30 mins
Haematology
Abstract
This presentation will:
- Describe the clinical utility of Retic Hb content in the diagnosis of iron deficiency.
- Explain the development of external quality assessment for new parameters in automated counting.
- Review the performance data from the first two years of the UK NEQAS Retic Hb EQA programme.
Speakers
Dr Barbara De La Selle
Director, UK NEQAS Haematology. President, UK NEQAS Charity, UK NEQAS Haematology
An interesting case study of childhood malaria in East Kent
Haematology
An interesting case study of childhood malaria in East Kent
11am – 11.30am BST, 25 September 2025 ‐ 30 mins
Haematology
Learning outcomes
Through the discussion of a case study delegates will:
- Understand the roles of the malaria reference laboratory and bodies such as UKHSA in malaria tracking.
- Understand the importance and incidence of thrombocytopenia.
- Better appreciation of expecting the unexpected and incidental findings in the laboratory.
- Understand the importance of relevant clinical information and communication.
Speakers
Mr Graeme Bain
Senior Biomedical Scientist, East Kent Hospitals University NHS Foundation Trust
Learning the lessons from blood and blunders
Haematology
Learning the lessons from blood and blunders
11.30am – 12pm BST, 25 September 2025 ‐ 30 mins
Haematology
Abstract
We will review three key learning outcomes of the RCPath investigation initiated following the publication of the article Blood and Blunders.
- Staff competency
- What EQA does and does not do!
- Who are we loyal too!
Speakers

Rev Dr Gordon Sinclair
Senior Lecturer in Biomedical Science , London Metropolitan University
Meet The Experts: Haematology
Haematology
Meet The Experts: Haematology
12.45pm – 2pm BST, 25 September 2025 ‐ 1 hour 15 mins
Haematology
Bone marrow disorders
Haematology
Bone marrow disorders
2pm – 2.30pm BST, 25 September 2025 ‐ 30 mins
Haematology
Abstract
Learning outcomes
Speakers
Dr Fiona Clark
Consultant Haematologist, University Hospitals of North Midlands NHS Trust
The importance of the laboratory in diagnosis and research in anti-PF4 mediated thrombotic thrombocytopenic syndromes
Haematology
The importance of the laboratory in diagnosis and research in anti-PF4 mediated thrombotic thrombocytopenic syndromes
2.30pm – 3pm BST, 25 September 2025 ‐ 30 mins
Haematology
Abstract
Learning outcomes
Speakers
Dr Pip Nicolson
Associate Professor in Cardiovascular Science, University of Birmingham
Is the future of full blood count testing in sight?
Haematology
Is the future of full blood count testing in sight?
3pm – 3.30pm BST, 25 September 2025 ‐ 30 mins
Haematology
Learning outcomes
Delegates will:
- Be introduced to the Sight OLO and other AI based platforms
- Gain an understanding of the principles of AI imaging platforms in haematology
- See a comparison of results from the Sight OLO to those from a lab-based FBC analyser
- Gain an appreciation of the potentially utility of the Sight OLO and other AI-based testing platforms in the future
Speakers

Annabel Booth-Hankey
NMCPS Cross-Site Training Coordinator, University Hospitals of North Midlands NHS Trust
Opening and Closing Plenary programmes